Karin von Wachenfeldt

538 total citations
26 papers, 374 citations indexed

About

Karin von Wachenfeldt is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Karin von Wachenfeldt has authored 26 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 7 papers in Immunology. Recurrent topics in Karin von Wachenfeldt's work include Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Asthma and respiratory diseases (6 papers). Karin von Wachenfeldt is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Asthma and respiratory diseases (6 papers). Karin von Wachenfeldt collaborates with scholars based in Sweden, United States and United Kingdom. Karin von Wachenfeldt's co-authors include Pernilla Glader, Claes‐Göran Löfdahl, Stephen I. Rennard, Sebastian Möller, Johanna Lilja, Elisabet Wieslander, Lars Olsson, Irma Mahmutovic Persson, Tim Stevens and Sabina Janciauskiene and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Karin von Wachenfeldt

25 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin von Wachenfeldt Sweden	12	139	90	90	73	54	26	374
Nabeela Khan United States	11	104 0.7×	152 1.7×	108 1.2×	29 0.4×	49 0.9×	19	478
Gökhan Demir Türkiye	12	85 0.6×	100 1.1×	30 0.3×	29 0.4×	85 1.6×	31	408
Patricia E. Losco United States	13	109 0.8×	130 1.4×	62 0.7×	43 0.6×	23 0.4×	22	423
Yuan Bian China	11	59 0.4×	136 1.5×	98 1.1×	33 0.5×	163 3.0×	38	515
Kristine Devito United States	10	72 0.5×	94 1.0×	97 1.1×	149 2.0×	71 1.3×	12	370
Takahiro Kageyama Japan	12	28 0.2×	89 1.0×	133 1.5×	41 0.6×	58 1.1×	34	408
Choon-Taek Lee South Korea	9	172 1.2×	124 1.4×	24 0.3×	25 0.3×	57 1.1×	20	404
Trivikram Dasu United States	10	53 0.4×	85 0.9×	237 2.6×	31 0.4×	38 0.7×	13	489
Praveen Neeli United States	11	57 0.4×	294 3.3×	141 1.6×	68 0.9×	127 2.4×	23	541
G E Winterrowd United States	11	53 0.4×	83 0.9×	177 2.0×	162 2.2×	31 0.6×	11	418

Countries citing papers authored by Karin von Wachenfeldt

Since Specialization

Citations

This map shows the geographic impact of Karin von Wachenfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin von Wachenfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin von Wachenfeldt more than expected).

Fields of papers citing papers by Karin von Wachenfeldt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin von Wachenfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin von Wachenfeldt. The network helps show where Karin von Wachenfeldt may publish in the future.

Co-authorship network of co-authors of Karin von Wachenfeldt

This figure shows the co-authorship network connecting the top 25 collaborators of Karin von Wachenfeldt. A scholar is included among the top collaborators of Karin von Wachenfeldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin von Wachenfeldt. Karin von Wachenfeldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Persson, Irma Mahmutovic, Jian Liu, René in ‘t Zandt, et al.. (2024). In vivo MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin. Frontiers in Medicine. 11. 1276420–1276420. 3 indexed citations

Hansen, Nils, et al.. (2024). Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment. Journal for ImmunoTherapy of Cancer. 12(12). e009523–e009523. 6 indexed citations

Zandt, René in ‘t, et al.. (2024). Contrast enhanced longitudinal changes observed in an experimental bleomycin-induced lung fibrosis rat model by radial DCE-MRI at 9.4T. PLoS ONE. 19(9). e0310643–e0310643. 3 indexed citations

Veltien, Andor, Tom W. J. Scheenen, René in ‘t Zandt, et al.. (2023). Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tracer to assess inflammation and fibrogenesis in a reproducible lung injury rat model: a multimodal imaging study. SHILAP Revista de lepidopterología. 3. 1306251–1306251. 7 indexed citations

Millrud, Camilla Rydberg, Adnan Deronic, Elin Jaensson Gyllenbäck, et al.. (2022). Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy. Cancer Immunology Immunotherapy. 72(3). 667–678. 13 indexed citations

Persson, Irma Mahmutovic, Jian Liu, Anders Örbom, et al.. (2020). Longitudinal Imaging Using PET/CT with Collagen-I PET-Tracer and MRI for Assessment of Fibrotic and Inflammatory Lesions in a Rat Lung Injury Model. Journal of Clinical Medicine. 9(11). 3706–3706. 17 indexed citations

Persson, Irma Mahmutovic, et al.. (2020). Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease Induced by Bleomycin. Frontiers in Physiology. 11. 584–584. 19 indexed citations

Persson, Irma Mahmutovic, Karin von Wachenfeldt, John C. Waterton, & Lars Olsson. (2020). Imaging Biomarkers in Animal Models of Drug-Induced Lung Injury: A Systematic Review. Journal of Clinical Medicine. 10(1). 107–107. 4 indexed citations

Wachenfeldt, Karin von, Anna-Karin L. Robertson, Jacob Fog Bentzon, et al.. (2018). Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs. Journal of Diabetes Research. 2018. 1–12. 13 indexed citations

10.

Persson, Irma Mahmutovic, Karin von Wachenfeldt, Simon F. Campbell, et al.. (2018). Systematic review: In vivo imaging in animal models relevant to drug-induced Interstitial lung disease (DIILD). PA2956–PA2956. 1 indexed citations

11.

Persson, Irma Mahmutovic, et al.. (2018). Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD. PA2958–PA2958. 1 indexed citations

12.

Wachenfeldt, Karin von, Jacob Fog Bentzon, Lars B. Nielsen, et al.. (2016). Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesions. International Journal of Cardiology. 215. 506–515. 17 indexed citations

13.

Li, Shijie, Paul Kievit, Ganesh Kolumam, et al.. (2013). Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques. Molecular Metabolism. 2(3). 256–269. 36 indexed citations

14.

Rennard, Stephen I. & Karin von Wachenfeldt. (2011). Rationale and Emerging Approaches for Targeting Lung Repair and Regeneration in the Treatment of Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society. 8(4). 368–375. 21 indexed citations

15.

Lindahl, Maria, Monika Malm-Erjefält, Karin von Wachenfeldt, et al.. (2007). Cooperative Inhibitory Effects of Budesonide and Formoterol on Eosinophil Superoxide Production Stimulated by Bronchial Epithelial Cell Conditioned Medium. International Archives of Allergy and Immunology. 143(3). 201–210. 10 indexed citations

16.

Shaker, Saher Burhan, Karin von Wachenfeldt, Susanne Larsson, et al.. (2007). Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers. The Clinical Respiratory Journal. 2(1). 17–25. 25 indexed citations

17.

Glader, Pernilla, Karin von Wachenfeldt, & Claes‐Göran Löfdahl. (2005). Systemic CD4+ T-cell activation is correlated with FEV1 in smokers. Respiratory Medicine. 100(6). 1088–1093. 24 indexed citations

18.

Glader, Pernilla, et al.. (2005). αEβ7 Expression on CD8+ T-Cells in COPD BAL Fluid and on TGF-β Stimulated T-Cells In Vitro. Lung. 183(2). 123–138. 9 indexed citations

19.

Glader, Pernilla, et al.. (2005). C-36 peptide, a degradation product of α1-antitrypsin, modulates human monocyte activation through LPS signaling pathways. The International Journal of Biochemistry & Cell Biology. 38(4). 563–575. 34 indexed citations

20.

Glader, Pernilla, Sebastian Möller, Johanna Lilja, et al.. (2005). Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells. Respiratory Medicine. 100(5). 818–827. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact